Asia accounts for almost 60% of the global incidence of cervical cancer, with India and China together contributing to more than a third of all cases and deaths.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more